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Abstract
Background:  RNA-binding motif protein 19 (RBM19, NCBI Accession # NP_083038) is a
conserved nucleolar protein containing 6 conserved RNA recognition motifs. Its biochemical
function is to process rRNA for ribosome biogenesis, and it has been shown to play a role in
digestive organ development in zebrafish. Here we analyzed the role of RBM19 during mouse
embryonic development by generating mice containing a mutation in the Rbm19 locus via gene-trap
insertion.
Results:  Homozygous mutant embryos failed to develop beyond the morula stage, showing
defective nucleologenesis, activation of apoptosis, and upregulation of P53 target genes. A unique
feature of RBM19 is its localization to the cytoplasm in morula stage-embryos, whereas most other
nucleolar proteins are localized to the nucleolar precursor body (NPB). The nucleoli in the Rbm19
mutant embryos remain immature, yet they can carry out rRNA synthesis. The timing of
developmental arrest occurs after expression of the inner cell mass markers OCT3/4 and
NANOG, but prior to the specification of trophectoderm as reflected by CDX2 expression.
Conclusion:  The data indicate that RBM19 is essential for preimplantation development,
highlighting the importance of de novo nucleologenesis during this critical developmental stage.
Background
During early embryogenesis, the zygotic nucleolus assem-
bles from a ground state following the disassembly of the
maternal nucleolus after pronuclear fusion [1]. "De novo"
nucleologenesis begins in the mouse at the end of the 2nd
cell cycle with the initiation of ribosomal RNA transcrip-
tion. An early morphological intermediate of the reform-
ing nucleolus is the nucleolus precursor body (NPB) [2].
The NPB can be detected through the morula stage, after
which it progressively adopts the classic tripartite mor-
phology as seen in the blastocyst and thereafter. Ribos-
omal RNA transcription begins on the surface of the
sphere, where the nucleolar organizing regions (NORs) of
the genome are located [3]. In contrast to somatic (i.e.
post-mitotic) nucleologenesis, the mechanism and role in
development of de novo nucleologenesis are not well
understood.
The role of nucleolar proteins during early mouse devel-
opment has been investigated by gene targeting in the
mouse. In virtually all cases, genetic ablation of protein
function results in developmental arrest prior to birth, but
at stages that might not be predictable a priori based on
the encoded protein's function. For example, in embryos
mutant for the proteins involved in ribosomal (r)RNA
synthesis or processing, such as pescadillo-1 (PES-1) [4],
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fibrillarin [5], RNA polymerase 1–2 [6] and Surf6 [7],
arrest occurs at the morula stage. However, in the tif1a
mutant, which ablates a protein mediating the earlier
process of rRNA transcription, arrest occurs after implan-
tation [8]. Knockout of B23/nucleophosmin, which is
required for rRNA processing and also chromosome seg-
regation, arrested development between E9.5 and E12.5
[9]. A unifying feature in all these mutant embryos was
disruption of the nucleolus and increased apoptosis. It
remains unclear to what extent mutant phenotypes arise
from a shortage of ribosomes or from stress signals origi-
nating from a dysfunctional nucleolus.
Here we studied the role of RBM19 during early mouse
embryonic development. RBM19 is a conserved nucleolar
protein distinguished by its 6 RNA recognition motifs
(RRM) [10-12]. It has been implicated in processing pre-
ribosomal RNA [11]. It was also found to be essential for
digestive organ development in the zebrafish in two inde-
pendent genetic screens [12,13], and is expressed prefer-
entially in the progenitor compartment of the
mammalian intestine [14]. To assess its function during
mouse development, we generated a mutant containing a
gene-trap insertion into the Rbm19  locus. As described
below, we found that RBM19 is required for preimplanta-
tion development.
Results
Molecular characterization of the Rbm19XC768 mutation
We identified an ES cell line containing a gene-trap inser-
tion in the Rbm19  locus  Rbm19Gt(pGT1Lxf)XC768
(Rbm19GtXC768) by searching the BayGenomics database
http://baygenomics.ucsf.edu/old_index.html[15]. The
insertion is within intron 16 and predicted to create a
transcript that joins the sequences from exon 16 to the β-
galactosidase open reading frame. The exact insertion site
was determined by empirically testing a series of PCR
primer pairs consisting of one Rbm19-specific primer and
one primer to various sites in the gene trap vector. PCR
products were sequenced, enabling detection of the inser-
tion site. The gene trap message should encode a fusion
protein in which the two C-terminal RRM domains are
omitted and substituted with the β-galactosidase-neomy-
cin resistance protein, leaving the four N-terminal RRM
domains intact (Figure 1A). In heterozygotes, by quantita-
tive PCR we detected 5 copies of the insertion vector.
These animals had been outcrossed at least 4 times, yield-
ing 50% heterozygous offspring, indicating that the mul-
tiple copies are tightly linked. The most likely explanation
is that multiple copies were integrated in tandem, which
is known to occur with plasmid vectors such as pGT1Lxf
when electroporated into ES cells [16]. Since it is formally
possible that the integrated DNA could get excised during
splicing, we characterized the transcripts produced in
homozygous vs. heterozygote embryos by reverse tran-
scriptase (RT)-PCR. Using Rbm19-specific primers to
exons flanking the insertion site or an Rbm19-specific for-
ward primer paired with a β-geo reverse primer, we could
detect both wild-type and mutant-specific bands, respec-
tively. We detected both bands in the heterozygotes, but
only the mutant band in homozygote-derived cDNA.
To further demonstrate that the β-geo insertion indeed
generated a fusion protein we performed a Western blot
on extract from duodenum of Rbm19GtXC768/+ adult mice,
using anti-RBM19 antibody directed against an epitope
near the amino terminal of the protein [14]. As expected,
we detected a distinct, albeit faint, band corresponding to
the predicted size of the RBM19-β geo fusion protein (191
kilodaltons (kD)) in the heterozygote but not in the wild-
type extract (Figure 1C). We could not perform Western
blotting on homozygous mutant embryos due to arrest at
the morula stage (see below) and consequent lack of ade-
quate material.
We fine-mapped the insertion site to single nucleotide res-
olution using a series of PCR primers complementary to
mouse genomic sequences distributed across intron 16.
Sequencing the PCR products allowed us to identify the
junctions between gene-trap vector and genomic DNA.
We did not detect any deletions. We were then able to per-
form allele-specific multiplex PCR for all subsequent gen-
otyping (Figure 1D).
Characterization of the Rbm19GtXC768 mutant phenotype
We generated chimeric mice by blastocyst injection, and
bred these to obtain founder Rbm19GtXC768/+ mice. The
progeny of heterozygote outcrosses were in the expected
Mendelian ratio (50%, n > 300) and the heterozygote
mice displayed no discernible mutant phenotype, surviv-
ing beyond 2 years without overt pathology. Interbreed-
ing the Rbm19GtXC768/+ mice yielded neither live births nor
embryos prior to E6.5 that were homozygous. At E3.5 the
intercrosses consistently yielded a mixture of morula and
blastocyst-stage embryos (Table 1). Genotyping of these
embryos demonstrated that the morula-stage embryos
were homozygote mutants, whereas the blastocyst stage
embryos were uniformly Rbm19+/+ or Rbm19GtXC768/+ (Fig-
ure 2A). Visual screening at E3.5 was 93% predictive for
genotype (n = 70). Prior to E3.5, intercrosses yielded early
stage embryos that were indistinguishable from each
other, despite the presence of homozygote mutants
among these progeny. To discern if the mutant embryos at
E3.5 were arrested at this stage or simply delayed, we cul-
tured the embryos. Normal-appearing E3.5 embryos
formed expanded blastocysts, but the E3.5 morula-stage
embryos remained arrested at the morula stage for an
additional day, and then degenerated (Figure 2B). Thus
the Rbm19GtXC768/GtXC768 embryos arrest prior to formingBMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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Figure 1 (see legend on next page)BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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the blastocyst. No wild-type intercrosses in the C57/BL6
background yielded embryos similarly delayed at E3.5.
RBM19 localization during preimplantation development
To understand how the RBM19 protein might function
during early development, we determined its subcellular
localization by immunofluorescence. At the 4–8 cell
stages we found RBM19 localized to discrete foci distrib-
uted throughout the cytoplasm and nucleoplasm (Figure
3). This result was surprising, since other nucleolar pro-
teins such as nucleolin, fibrillarin [17], NOPP140 [18]
and pescadillo-1 (PES-1) [4] localize to the periphery of
the NPB in cleavage and morula stage embryos. Double
staining with B23 confirmed that prominent NPBs can be
visualized at this stage, but most of the RBM19 does not
localize to these structures. As the blastocyst forms,
RBM19 becomes increasingly localized to the nucleolus
and less to the cytoplasm. By the late blastocyst stage,
when nucleologenesis is largely completed, we observed
only a few cytoplasmic RBM19-positive foci, with most of
the RBM19 protein seen in the nucleolus.
Since RBM19 contains 6 RRMs and has been shown to
bind RNA [12,19], we considered the possibility that
RBM19 localizes to P-bodies, which store and process
maternal RNA in the oocyte [20]. We performed double
immunofluorescence staining for RBM19 and the P-body-
specific protein GW182, and found that they do not colo-
calize (Additional file 1), indicating that RBM19-positive
cytoplasmic foci and P-bodies are distinct structures.
Nucleologenesis is disrupted in Rbm19GtXC768/Gt XC768 
mutant embryos
Between the morula and blastocyst stages, the NPB under-
goes a morphogenic transition to a mature, tripartite
nucleolus [2]. As shown in Figure 3, this transition coin-
cides with the relocalization of RBM19 from cytoplasm to
nucleolus, suggesting that these two processes may be
linked. To test if RBM19 function may be required to form
the mature nucleolus, we performed immunostaining for
the nucleolar markers B23 and fibrillarin in the
Rbm19GtXC768/GtXC768 embryos (Figure 4A). The predomi-
nant B23 and fibrillarin staining patterns in the mutant
embryos resemble that of the wild-type morula. In most
cases we saw B23 and fibrillarin localized to large rings,
consistent with the periphery of NPBs. To further charac-
terize nucleologenesis in the Rbm19GtXC768/GtXC768 mutants
we examined the embryos using transmission electron
microscopy (Figure 4B). The mutant E3.5 embryos lack
the mature, tripartite nucleoli clearly evident in wild-type
blastocysts. Instead, the mutants contain spheres resem-
bling NPBs, indicating arrest of nucleologenesis.
Rbm19GtXC768/GtXC768 gene-trap characterization Figure 1 (see previous page)
Rbm19GtXC768/GtXC768 gene-trap characterization. (A) The insertion site of the gene trap vector is in intron 16 (*), result-
ing in loss of RRMs 5 and 6, along with the addition of a 116 kD β-geo protein. The exact insertion site is shown by the 
sequences flanking the gene trap insertion. The nucleotide number corresponds to the sequence available at NCBI accession 
NT_078458.6. The bold nucleotides represent the primer sequences we used to detect the wild-type Rbm19 allele. (B) RT-
PCR shows no detectable Rbm19+ transcript in the mutant E3.5 embryos using Rbm19-specific primers made to exons flanking 
the insertion site (red arrows, panel A). The expected product was detected when using an Rbm19-specific forward primer and 
β-geo reverse primer in the mutant embryos. (C) Western blot for RBM19 (amino-terminal epitope [14]) shows the expected 
191 kD fusion protein band in the heterozygous mouse intestine (arrow), but not in homozygous wild-type. (D) 32P-labeled 
PCR genotyping of E3.5 embryos from Rbm19GtXC768/+ intercrosses. The embryos were genotyped by a duplex PCR strategy. 
Rbm19-specific primers amplify a 296-bp DNA fragment across the insertion site (panel A, WT), which is disrupted by the gen-
etrap vector in the mutant. β-geo-specific primers amplify a 507-bp fragment from the gene trap vector (panel B, 
Rbm19GtXC768.)
Table 1: Genotypes of the offspring and embryos from 
Rbm19GtXC768/+ intercrosses
Stage Number of embryos (%)
+/+ +/- -/- ND
E3.5 11(16%) 41(58%) 13(19%) 5(7%)
E6.5 2(33%) 4(67%) 0 0
E7.5 5(45%) 6(55%) 0 0
E8.5 4(40%) 5(50%) 0 1(10%)
E9.5 4(50%) 4(50%) 0 0
E10.5 5(71%) 2(29%) 0 0
E11.5 1(33%) 2(67%) 0 0
E12.5 2(67%) 1(33%) 0 0
3 Week 17(30%) 40(70%) 0 0
E6.5-3 weeks 40 64 0 1BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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Rbm19GtXC768/GtXC768 embryos undergo morula arrest Figure 2
Rbm19GtXC768/GtXC768 embryos undergo morula arrest. (A) Live stereoscope images of Rbm19GtXC768/+, Rbm19+/+ or 
Rbm19GtXC768/GtXC768 E3.5 embryos (confirmed subsequently by genotyping). Homozygous mutants fail to form an inner cell 
mass (+), trophectoderm cell layer (arrow head), and blastocoel cavity (*). (B) Live images of embryos cultured in vitro. 
Embryos derived from Rbm19GtXC768/+ intercrosses were explanted at E3.5 (day 0), and grown in KSOM for the indicated 
number of days. Approximately 25% of the embryos arrested in the morula stage; the others hatched from the zona pellucida 
(Day 2) and continued to develop.BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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Since the nucleolus is generated by the collective action of
the ribosome biogenesis apparatus, we also assessed
whether rRNA transcription might be impaired in the
Rbm19GtXC768/GtXC768 mutant. We measured BrUTP incor-
poration in cultured embryos by double immunofluores-
cence staining with anti-BrdU and anti-fibrillarin
antibodies (Additional file 2). We found that both wild-
type and mutant embryos incorporated BrUTP that colo-
calized with fibrillarin. This indicated that RBM19 is not
required for the assembly of the rRNA transcription appa-
ratus on the surface of the NPB.
Timing of developmental arrest in Rbm19GtXC768/GtXC768 
mutant embryos
A feature of the Rbm19GtXC768/GtXC768 mutant phenotype is
failure of the morula to undergo compaction (Figure 2).
In the mutant, the margins between individual blast-
omeres can still be appreciated at the 16-cell stage, by
which time compaction has already occurred in wild-type
embryos. E-cadherin is a cell adhesion molecule essential
for compaction of the morula [21]. To test if E-cadherin is
expressed and properly localized in the mutant embryos,
we performed whole mount immunofluorescence stain-
ing. E-cadherin was present and appeared to be normally
localized between the blastomeres (Additional file 3),
although the outline of the cells revealed irregular borders
and abnormal cell shapes. This suggests that the absence
RBM19 is expressed in a dynamic pattern during preimplantation development Figure 3
RBM19 is expressed in a dynamic pattern during preimplantation development. (a-d) RBM19 immunostaining in the 
8-cell stage embryos localizes to cytoplasmic granules. In contrast, B23 is localized around the NPB. (e-h) In the early blasto-
cyst, RBM19 begins to co-localize with B23 within nuclear foci, but is also noted in the cytoplasm. (i-l) In the mid-blastocyst, the 
inner cell mass (ICM) is becoming more distinct (oriented toward 5 o'clock) and RBM19 continues to co-localize increasingly 
with B23. RBM19 is retained in the cytoplasm to a greater extent in the cells that are located in the presumptive ICM. (M-P) In 
the late blastocyst the ICM is easily identified oriented toward 2 o'clock. The localization of RBM19 is mostly concordant with 
B23 thereafter.BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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Nucleologenesis in the Rbm19GtXC768/GtXC768 mutant embryos Figure 4
Nucleologenesis in the Rbm19GtXC768/GtXC768 mutant embryos. (A) Embryos from an Rbm19GtXC768/+ intercross were 
sorted based on appearance and designated either wild-type-appearing (Rbm19GtXC768/+ or Rbm19+/+) or Rbm19GtXC768/
GtXC768mutants. Embryos at the indicated stages were stained with anti-B23 (green) and anti-fibrillarin (red) antibodies. (a-d) 
B23 and fibrillarin localization reveals the morphology of the NPB in E2.5 wild-type embryos. (e-h) At E3.5 nucleoli are smaller 
and more numerous than earlier stage shown in panels a-d (i-j) and (k-l). In the Rbm19GtXC768/GtXC768 mutant, B23 and fibrillarin, 
respectively, show a heterogeneous pattern, mostly resembling NPBs as seen in panel b, but with a few smaller foci suggesting 
partial nucleolar differentiation. (B) Electron micrograph of E3.5 wild type and Rbm19GtXC768/GtXC768 mutant embryos. Wild type 
embryos have mature nucleoli with differentiated nucleolar regions including fibrillar components (FC), dense fibrillar compo-
nents (DFC), and granular components (GC). Mutant blastomeres (5 embryos examined) contained multiple fibrillar spheres 
(FS) that were presumed to be the nucleolar precursor bodies, but failed to form well-differentiated nucleoli.BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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Early lineage marker expression in Rbm19GtXC768/GtXC768 mutant embryos Figure 5
Early lineage marker expression in Rbm19GtXC768/GtXC768 mutant embryos. Embryos from an Rbm19GtXC768/+ intercross 
were sorted based on appearance and designated either wild-type-appearing (Rbm19GtXC768/+ or Rbm19+/+) or Rbm19GtXC768/
GtXC768 mutants. (A) Double immunofluorescence staining for embryonic stem cell markers OCT-3/4 and NANOG reveals uni-
form expression in cleavage stage embryos, with progressive segregation of immunopositive cells to the inner cell mass in wild-
type-appearing E3.5 embryos. In Rbm19GtXC768/GtXC768 embryos arrested at the 16-cell stage, the level of OCT-3/4 is diminished, 
but NANOG expression remains comparable to WT morula. There is no spatial segregation across the mutant embryos for 
either protein. (B) Double immunofluorescence staining for the trophectoderm marker CDX2 and the nucleolar protein Fibril-
larin (positive control). In the wild-type-appearing embryos CDX2 expression was found in a subset of cells corresponding to 
the prospective trophectoderm, whereas in the Rbm19GtXC768/GtXC768 embryos there was no CDX2 expression detectable.BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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or mislocalization of E-cadherin is unlikely to be the rea-
son for failure of compaction.
To assess whether Rbm19GtXC768/GtXC768 mutant embryos
form the first embryonic lineages, we performed immu-
nostaining for the lineage markers OCT-3/4, NANOG and
CDX2 (Figure 5). Normally, OCT-3/4 and NANOG pro-
teins are expressed in all the blastomeres of morula-stage
embryos. Then, in concert with morula compaction, the
outer blastomeres become specified to form the trophec-
toderm lineage. These cells gradually lose OCT-3/4 and
NANOG expression and begin to express the trophecto-
derm marker CDX2. In the Rbm19GtXC768/GtXC768 mutants,
OCT3/4 expression is substantially diminished, whereas
NANOG expression remains similar to wild-type moru-
lae. Notably, there was no CDX2 expression detectable in
the mutants, indicating that developmental arrest occurs
prior to trophectoderm specification.
Apoptosis of blastomeres in Rbm19GtXC768/GtXC768 mutant 
embryos
To characterize the cellular process that leads to develop-
mental arrest, we tested markers for apoptosis in the E3.5
Rbm19GtXC768/GtXC768mutant embryos. We performed both
TUNEL assay and immunostaining for cleaved caspase 3,
and found that about 90% of the mutant nuclei were pos-
itive for both markers of apoptosis (22/24 cells) (Figure
6A and 6B, respectively). In contrast, the wild-type
embryos showed minimal staining for TUNEL and only
background staining for caspase 3. The P53 tumor sup-
pressor protein is a known inducer of apoptosis and has
been shown to mediate the nucleolar stress response [22].
We tested the transcriptional activation of known P53 tar-
gets in the Rbm19GtXC768/GtXC768 mutant embryos by semi-
quantitative RT-PCR (Figure 6C). We show that p21, Bax,
and  cyclinG1  are upregulated in the Rbm19GtXC768/
GtXC768mutant embryos. Thus, both arms of the P53 effec-
tor pathway-cell cycle arrest and apoptosis-appear to be
upregulated.
One possible reason for the timing of the Rbm19GtXC768/
GtXC768mutant phenotype is the exhaustion of maternal
gene product at the 8–16 cell stage, assuming that Rbm19
gene product is present prior to zygotic transcription. By
RT-PCR using RNA from wild-type 2-cell stage embryos
we detected Rbm19 expression (Additional file 4). Thus
Rbm19 may be required even earlier than the 8–16 cells
stage, since the early Rbm19GtXC768/GtXC768 mutant pheno-
type may be complemented by wild-type gene product
from the heterozygote mother.
Discussion
Here we report that a gene-trap insertion, resulting in dis-
ruption of the nucleolar protein RBM19, arrests embry-
onic development in the mouse prior to implantation.
The mutant allele resulting from the gene trap may be par-
tially functional, and maternal Rbm19 RNA is present in
the 2-cell stage embryo, suggesting that RBM19 could be
required even earlier than E3.5. In somatic cells RBM19 is
a component of the nucleolus, and the timing of arrest
(8–16 cell stage) coincides with the formation of the
nucleolus. Also, localization of RBM19 changes from
cytoplasm to nucleolus at the same stage as developmen-
tal arrest of the Rbm19GtXC768/GtXC768 mutant. The assembly
of the nucleolus is a prerequisite for embryonic develop-
ment [1]. Failure of nucleologenesis could trigger a nucle-
olar stress response that induces cell cycle arrest and/or
apoptosis via activation of P53 [22] as one of many possi-
ble mechanisms to account for the Rbm19GtXC768/
GtXC768mutant phenotype.
There are notable similarities and differences between
RBM19 and other nucleolar proteins that have been stud-
ied by genetic inactivation in the mouse. Several others
were found to be required at the morula stage, including
fibrillarin [5], PES-1 [4], SURF6 [7], BYSL [23], and RNA
polymerase 1–2[6]. These proteins all participate in vari-
ous aspects of rRNA synthesis or processing. Thus
impaired ribosome biogenesis may be the common
molecular defect underlying these phenotypes. However,
other genes that encode proteins essential for ribosome
biogenesis do not cause morula arrest upon their muta-
tion. For example, TIF1a is essential for rRNA transcrip-
tion [24], and its ablation in the mouse leads to nucleolar
disruption and p53-mediated apoptosis [8]. Yet, Tif1a
mutant embryos survive to E9.5 (albeit 10-fold smaller
than wild-type) and form rudiments of most organs. Sim-
ilarly, ablation of the B23  gene results in embryonic
lethality and genomic instability, but the embryos survive
to E9.5-E12.5 [9]. Thus, a ribosome biogenesis defect can-
not be predicted to uniformly induce early embryonic
lethality. The reason for this may be that, while nucleolo-
genesis and ribosome biogenesis are intimately linked,
there may be differential effects on one and not the other,
since the nucleolus has other roles as well. It may be diffi-
cult to sort out exactly which phenotypes are attributable
to a shortfall in ribosome biogenesis and which are due to
induction nucleolar stress signals. Since stress signals may
be mediated in large by P53, analyzing the effects of
nucleolar protein mutations in a P53  null background
may provide some clues. For example, genetic inactivation
of P53 mitigated, but did not completely rescue, the loss
of B23 in the mouse [9]. We have generated Rbm19GtXC768/
GtXC768 /p53-/- double mutants and in preliminary studies it
appears that loss of p53 does not rescue the Rbm19 mutant
phenotype.
Nucleologenesis in the early embryo is first detectable
upon activation of rRNA transcription on the surface of
the NPB after the 2nd cell cycle [3]. The developmentalBMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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Apoptosis and P53 activation in Rbm19GtXC768/GtXC768 mutant embryos Figure 6
Apoptosis and P53 activation in Rbm19GtXC768/GtXC768 mutant embryos. Embryos from an Rbm19GtXC768/+ intercross 
were sorted based on appearance and designated either wild-type-appearing (Rbm19GtXC768/+ or Rbm19+/+) or Rbm19GtXC768/
GtXC768 mutants. (A) Detection of apoptosis by in situ TUNEL assay. Wild type-appearing blastocysts exhibit very few TUNEL-
positive cells, whereas extensive apoptosis was observed in the growth-arrested Rbm19GtXC768/GtXC768 embryos. (B) Cleaved 
caspase-3 staining of Rbm19GtXC768/GtXC768 embryos showed strong staining of most cells in mutant embryos, suggesting apop-
totic cell death. (C) P53 target gene expression in wild type appearing and Rbm19GtXC768/GtXC768 mutant E3.5 embryos revealed 
by semi-quantitative RT-PCR. p21, Bax and CyclinG1 are upregulated in the mutant; GAPDH was used as a loading control.BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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events between the onset of rRNA transcription and nucle-
olar maturation are poorly understood. Nucleolar pro-
teins studied to date localize to the surface of the
nucleolar precursor body (NPB) [2]. We show that RBM19
protein does not conform to this localization pattern, but
instead remains in the cytoplasm through the morula
stage, then localizes to the nucleolus in the blastocyst.
This would suggest that RBM19 plays a role the early
embryo distinct from its previously characterized function
in rRNA processing. One possible role might be coordi-
nating other nucleolar proteins for transport to the
nucleus, to insure proper nucleolar assembly [19].
Our finding that CDX2 expression is completely absent in
Rbm19GtXC768/GtXC768 mutants identifies the first lineage
specification event in the embryo as the stage at which
developmental arrest occurs. It is tempting to speculate
that the nucleolus plays a permissive role in regulating
this developmental step. According to such a model, the
developmental program may utilize the forming nucleo-
lus as a sensor of normal development. If nucleologenesis
is indeed determinative, failure of this process may repre-
sent one reason for arrest prior to implantation.
Conclusion
The Rbm19GtXC768 mutation induces arrest of development
as the nucleolus is maturing. Since nucleolar maturation
occurs coincident with the stage-specific localization of
RBM19 from the cytoplasm to the nucleolus, the underly-
ing cause of arrest may be failure of nucleologenesis in
concert with a P53-mediated stress response.
Methods
Insertional mutation of the Rbm19 locus
A mouse ES cell line (XC768) containing an insertional
mutation of the Rbm19 locus was generated by BayGen-
omics [15]. The gene-trap vector used (pGT1Lxf) contains
a splice-acceptor sequence upstream of the reporter gene
βgeo (a fusion of β-galactosidase and neomycin phospho-
transferase II) resulting in the generation of a truncated
RBM19-β-geo fusion protein. ES cell line XC768 was
injected into C57BL/6 blastocysts to generate chimeric
mice, which were then intercrossed to establish the
Rbm19GtXC768 mutant germline. The mice were weaned at
21 days of age, and housed in a barrier facility with a 12 h
light/12 h dark cycle. All animal work was carried out in
compliance with internationally recognized guidelines as
per the Animal Welfare Act, under protocols approved by
the MCW IACUC (protocol# 235-04-2).
Genotype analysis
Mouse genomic tail DNA was prepared according to
standard procedures. A duplex PCR strategy was devel-
oped to distinguish between the wild type and
Rbm19GtXC768  mutant alleles. Rbm19-specific primers
amplify a 296-bp DNA fragment across the insertion site,
which is disrupted by the gene trap vector in the mutant.
(Rbm19-forward: 5'-ATTGCCCTTGCTCACATTTC-3'.
Rbm19-reverse: 5'-AGGCCTGACCACACTGACTT-3'.) β-
geo primers amplify a 507-bp fragment from the gene trap
vector. (β-geo-forward: 5'-CTGGCGTAATAGCGAA-
GAGG-3'.  β-geo-reverse: (5'-CCGCCACATATCCT-
GATCTT-3').
Blastocyst collection, culture in vitro, and genotyping
Blastocysts were collected at embryonic development day
3.5 (E3.5) by flushing the uterus with M2 (MR-015P-D,
Chemicon). The blastocysts were transferred to KSOM
(MR-020P-F, Chemicon), covered with mineral oil (M-
5310, Sigma) and cultured at 37°C with 5% CO2. For gen-
otyping, E3.5 embryos were collected into PCR tubes with
10 μL 1×PCR buffer (Qiagen), to which were added 1 μL
400 μg/ml proteinase K (#03115828001, Roche) incu-
bated for 2 h at 50°C, followed by incubation at 98°C for
10 min to inactivate the proteinase K. The lysates were
cleared by a 5 min centrifugation at 3000 rpmand used
directly for PCR amplification.
RNA preparation and RT-PCR
RNA isolation from E3.5 embryos was performed using
the Nano-scale RNA Purification Kit (MPS04050, EPI-
CENTRE Biotechnologies). Reverse transcription was car-
ried out using a random hexamer primer. Gene-specific
primers used are shown in Table 2. PCR products were
separate on 2% agarose gels and visualized by staining
with ethidium bromide.
Immunofluorescence Studies and TUNEL Assay
For immunofluorescence analysis, preimplantation
embryos at the indicated stages were incubated for 1
minute in acid Tyrodes solution (Specialty Media, MR-
004-D, Chemicon) to dissolve the zona pellucida, then
fixed in PBS/3.2% PFA for 5 minutes. After washing
briefly in PBS/10 mM glycine, embryos were perme-
ablized for 3 minutes in 0.5% Nonidet P-40 (in 1% BSA
PBS), then blocked in PBS/3.0%BSA for 1 hour at room
temperature, incubated with primary antibodies at 4°C
overnight, and then washed in block solution and incu-
bated with appropriate secondary antibodies (Molecular
Probes or Jackson Immunoresearch) diluted 1:500, and
counterstained with DAPI (0.1 μg/ml) for 5 min at room
temperature. Immunostained embryos were placed on
microscope slides with Gel/Mount (#M01, Biomeda) and
covered with glass cover slips. Fluorescence was captured
using a mechanized Zeiss Axioplan II microscope driven
by OpenLab (Improvision) to generate z-stacks (0.2 μm
steps). Z-stacks were deconvolved using Volocity 3.0
(Improvision) via an iterative algorithm. Apoptosis was
detected by the TdT-mediated dUTP-fluorescein nick end-
labeling (TUNEL) assay by using the In Situ Cell DeathBMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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Detection kit (Cat# 12 156 792 910, Roche). In all cases,
embryos shown are representative of at least 3 independ-
ent experiments, in which about 10 embryos (7–8 normal
and 2–3 mutant) were stained and imaged.
For the Br-UTP incorporation assays, permeablization was
performed with 100 μg/mL Saponin (Sigma, S4521-10G)
in KSOM for 5 minutes at room temperature, and then
washed with KSOM. Embryos were incubated with KSOM
supplemented with 200 μM Br-UTP for 60 minutes at
37°C. After washing with KSOM, embryos were fixed in
3.2% PFA/PBS for 5 minutes at room temperature. RNA
synthesis was monitored with anti-Br-dUTP antibody
(1:100, Sigma).
Real-time Quantitative PCR
The number of copies of the gene trap vector was deter-
mined by comparing the Cycle Threshold (Ct) between
Rbm19 and β-geo in heterozygote mice. PCR primers used
for genotyping were used to generate PCR products from
heterozygote mouse DNA. These were gel-purified and
quantified, and used to generate a standard curve for each
primer pair. Ct was measured using SYBR green and the
Biorad/MJ Research Opticon2.
Western blot analysis
Total mouse duodenum lysates were fractionated using
sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis and transferred onto a polyvinylidene difluoride mem-
brane (Millipore Corporation). After blocking with 5%
nonfat dry milk (Bio-Rad Laboratories, Inc., Hercules, CA)
for 3 h at room temperature, blots were incubated with a
1:500 dilution of RBM19 antibody [14] at 4°C overnight,
then incubated with 1:8000 horseradish peroxidase-con-
jugated anti-rabbit secondary antibody and developed
using the ECL system (Pierce Biotechnology Inc., Rock-
ford, IL).
Electron Microscopy
E3.5 embryos were fixed in 2% glutaraldehyde. After
dehydration, embryos were embedded in epoxy resin. Sec-
tions were contrasted with uranyl acetate and lead citrate
and examined using a Hitachi 600 electron microscope.
Primary antibodies
Anti-B23/nucleophosmin (cat# 32-5200, Zymed), anti-
GW182 (cat# ab15843, Abcam), ribosomal protein S6
(cat# 54D2 Cell Signaling), anti-fibrillarin (cat# ab5821,
Abcam), anti-Cleaved Caspase-3 (cat# 9661, Cell Signal-
ing), anti-nucleostemin (cat# AF1638, R&D systems).
Abbreviations
RBM19: RNA-binding motif protein 19; NPB: nucleolar
precursorbody; NORs: nucleolar organizing regions;
RRM: RNA recognition motifs; β-geo: a fusion of β-galac-
tosidase and neomycin phosphotransferase II; TUNEL:
TdT-mediated dUTP-fluorescein nickend-labeling; PES-1:
pescadillo-1; (kD: kilodaltons.
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Table 2: Primers used for semi-quantitative RT-PCR and conditions of PCR reaction
Gene Dir Primer sequences (5'-3') Product size Annealing temp (°C)
P21 F
R
GTCCAATCCTGGTGATGTCC
GTTTTCGGCCCTGAGATGT
410 55
Bax F
R
TGCAGAGGATGATTGCTGAC
ACTCCAGCCACAAAGATGGT
313 55
CyclinG1 F
R
AATGTTGCTGGGAAGTCAGG
GCAAGGTGCTGAGGTTTCTC
352 55
Rbm19 F
R
CGGAGCGAAGTAAGACTGTG
CTCTGTGGTGCTGAAGTTG
470 53
β-geo R AGT ATC GGC CTC AGG AAG ATC G 53
GAPDH F
R
ATTGTCAGCAATGCATCCTG
TTCAGCTCTGGGATGACCTTGCC
243 59BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
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Additional file 1
RBM19 and GW182 do not colocalize in the cytoplasm of 8-cell stage 
mice embryos. (A) Double staining of RBM19 (red) and GW182 
(green), counterstained with DAPI. (B) Enlargement of the box in panel 
A. The arrow shows GW182 positive foci in the cytoplasm. (C) RBM19 
immunofluorescence showing cytoplasmic foci (D) Merged image show-
ing disRBM19 and GW182 do not colocalize.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-115-S1.tiff]
Additional file 2
In situ assay for ribosomal RNA transcription. (A-D) E2.5 morula 
embryos derived from wild type mice were cultured in the presence of 
BrUTP and then immunostained to detect label incorporation. Panels 
show colocalization of BrUTP and Fibrillarin. (E-L) Embryos from a 
Rbm19GtXC768/+ intercross were sorted based on appearance and desig-
nated either wild-type-appearing (Rbm19GtXC768/+ or Rbm19+/+) or 
Rbm19GtXC768/GtXC768mutants. (E-H) E3.5 Rbm19XC768/+or+/+ were 
labeled with Br-UTP while cultured in vitro. Circles indicate colocaliza-
tion of Br-UTP-labeled RNA (green) with the fibrillarin (red). (I-L) 
Rbm19XC768/XC768 mutant embryos incorporated BrUTP in nucleoli com-
parable to wild-type embryos.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-115-S2.tiff]
Additional file 3
E-cadherin localization in Rbm19 mutant embryos. E-cadherin anti-
bodies were used to stain E3.5 embryos from a Rbm19XC768/+ in-cross. 
The surface cells of WT blastocyst-stage embryos were imaged (left panel), 
showing polygonal cells with staining at cell borders. The Rbm19XC768/
XC768 mutants remained in an uncompacted 8–16 cell stage, yet E-cad-
herin staining was evident at the cell borders. The cells were larger with 
more irregular shapes, suggesting failure of epithelial organization in the 
prospective trophectoderm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-115-S3.tiff]
Additional file 4
RT-PCR from 2-cell stage embryos showing maternal expression of 
Rbm19. Embryos flushed from the oviducts of mice 1 day after appear-
ance of the vaginal plug were at the 2-cell stage. RNA isolated from ten 
2-cell stage embryos (CD-1 strain) was subjected to reverse transcription 
and PCR using primers shown in Table 2. Agarose gel shows a band at 
about 500 bp (arrow), the expected size for the Rbm19-specific product. 
This demonstrates that Rbm19 RNA is deposited in the egg prior to ferti-
lization.
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[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-115-S4.tiff]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Developmental Biology 2008, 8:115 http://www.biomedcentral.com/1471-213X/8/115
Page 14 of 14
(page number not for citation purposes)
20. Eulalio A, I Behm-Ansmant, Izaurralde E: P bodies: at the cross-
roads of post-transcriptional pathways.  Nat Rev Mol Cell Biol
2007, 8:9-22.
21. Larue L, Ohsugi M, Hirchenhain J, Kemler R: E-cadherin null
mutant embryos fail to form a trophectoderm epithelium.
Proc Natl Acad Sci USA 1994, 91:8263-7.
22. Rubbi CP, Milner J: Disruption of the nucleolus mediates stabi-
lization of p53 in response to DNA damage and other
stresses.  Embo J 2003, 22:6068-77.
23. Adachi K, Soeta-Saneyoshi C, Sagara H, Iwakura Y: Crucial role of
Bysl in mammalian preimplantation development as an inte-
gral factor for 40S ribosome biogenesis.  Mol Cell Biol 2007,
27:2202-14.
24. Yuan X, Zhao J, Zentgraf H, Hoffmann-Rohrer U, Grummt I: Multi-
ple interactions between RNA polymerase I, TIF-IA and
TAF(I) subunits regulate preinitiation complex assembly at
the ribosomal gene promoter.  EMBO Rep 2002, 3:1082-7.